Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358070 · ClinicalTrials.gov registry record
Epidemiologic Study of Hepatocellular Carcinoma in the US
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 45
- Enrollment target
NCT02358070: Completed study, sponsored by Stanford University.
NCT02358070 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02358070 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is: * to investigate the risk factors of HCC among Americans with focus on lifestyle factors and energy balance. * to identify single nucleotide polymorphisms (SNPs) and haplotypes that are associated with HCC risk through a genome-wide search. * to assess if genetic susceptibility differs by hepatitis virus infection or lifestyle factors, and to explore if there are interplays or effect modifications between genetic factors and viral infection or lifestyle factors.
Primary Outcome
Lifetime physical activity will be measured by collecting data on major types of physical activity separately and by determining frequency, intensity, and duration of each activity using a combined modification of Friedenreich's lifetime physical activity questionnaire and Kriska's past year physical activity questionnaires.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-09-01 |
What the finished NCT02358070 record still lists
NCT02358070 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02358070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02358070 about?
NCT02358070 is a clinical study titled "Epidemiologic Study of Hepatocellular Carcinoma in the US". The purpose of this study is: * to investigate the risk factors of HCC among Americans with focus on lifestyle factors and energy balance. * to identify single nucleotide polymorphisms (SNPs) and haplotypes that are associated with HCC risk through a genome-wide search. * to assess if genetic susce...
What is the current status of trial NCT02358070?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2015-04. Estimated completion is 2016-09-01.
Who is sponsoring clinical trial NCT02358070?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia